Sacubitril/valsartan in PARADIGM-HF

Slides:



Advertisements
Similar presentations
Multifaceted roles for lipids in viral infection Nicholas S. Heaton, Glenn Randall Trends in Microbiology Volume 19, Issue 7, Pages (July 2011)
Advertisements

Ancient Endo-siRNA Pathways Reveal New Tricks Julie M. Claycomb Current Biology Volume 24, Issue 15, Pages R703-R715 (August 2014) DOI: /j.cub
Two views of brain function Marcus E. Raichle Trends in Cognitive Sciences Volume 14, Issue 4, Pages (April 2010) DOI: /j.tics
Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)
Volume 384, Issue 9961, Pages (December 2014)
Cancer drugs in 16 European countries, Australia, and New Zealand: a cross-country price comparison study  Dr Sabine Vogler, PhD, Agnes Vitry, PhD, Zaheer-Ud-Din.
Pharmacogenetics and future drug development and delivery
Projected health effects of realistic dietary changes to address freshwater constraints in India: a modelling study  Dr James Milner, PhD, Edward J M.
Volume 376, Issue 9734, Pages (July 2010)
Thank God for Richard Dawkins?
Fetal growth and ethnic variation
A mindfulness-based intervention to increase resilience to stress in university students (the Mindful Student Study): a pragmatic randomised controlled.
Gian Paolo Fadini, Angelo Avogaro  The Lancet Diabetes & Endocrinology 
Para-aortic lymphadenectomy in endometrial cancer
Abdominal lipohypertrophy without insulin injection
Intraoperative radiotherapy for early breast cancer
Understanding EMPA-REG OUTCOME
Volume 376, Issue 9734, Pages (July 2010)
Physical activity and prevention of type 2 diabetes
Pralidoxime for organophosphate poisoning
Political factors behind US global AIDS programmes slow-down
Plasma active glucagon-like peptide-1 (GLP-1) response in patients with type  2 diabetes during the liquid high-fat meal test at baseline, 12 weeks and.
Correction to Lancet Diabetes Endocrinol 2015; 3: 263–74
Theo Nicholaou, Rachel Wong, Ian D Davis  The Lancet 
Network for strong, national, public health institutes in west Africa
Nicola Low, Joost H Smid  The Lancet Public Health 
Non-surgical treatment of diabetic foot osteomyelitis
Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes:
Gene therapy—where are we?
Non-uraemic calciphylaxis with acral necrosis
Understanding EMPA-REG OUTCOME
Effect of supplementation with folic-acid on relation between plasma homocysteine, folate, and vitamin B12  Joe McPartlin, Helene McNulty, Eoin Quinlivan,
Water drinking and the heart
Incident diabetes in clinical trials of antihypertensive drugs
HIV myths should not be resuscitated
Volume 375, Issue 9732, Pages (June 2010)
Late-stage research for diabetes and related NCDs receives little funding: evidence from the NIH RePORTER tool  Pascal Geldsetzer, Till Bärnighausen 
Michael J Goldacre, Jenny J Maisonneuve  The Lancet 
Correction to Lancet Diabetes Endocrinol 2015; 3: 263–74
Confessions of a journal junkie
The wonders of the recurated Wellcome Collection
Follicular flushing in natural cycle IVF does not affect the luteal phase – a prospective controlled study  M. von Wolff, A. Kohl Schwartz, P. Stute,
Telling it like it isn't: truth and lies in a post-9/11 world
C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20 536 patients in the Heart Protection Study  Heart Protection.
Thank God for Richard Dawkins?
Low-technology approaches
The emotional journey of gestational diabetes
Does midlife obesity really lower dementia risk?
Prof GJB van Ommen, PhD, E Bakker, PhD, JT den Dunnen, PhD  The Lancet 
Trajectories of changes in glucose tolerance in a multiethnic cohort of obese youths: an observational prospective analysis  Alfonso Galderisi, MD, Cosimo.
Vitamin D status and ill health – Author's reply
What is type 2 diabetes? Medicine
Fetal growth and ethnic variation
Volume 372, Issue 9632, Pages (July 2008)
Volume 376, Issue 9737, Pages (July 2010)
Volume 368, Issue 9541, Pages (September 2006)
A remarkable report card on progress in COPD
Difficulties of surgery in the developing world: a personal view
Political factors behind US global AIDS programmes slow-down
Improving management of neonatal infections
Potential antitumour activity of pasireotide on pituitary tumours in acromegaly  Eva C Coopmans, Aart J van der Lely, Joppe J Schneiders, Sebastian J C.
Volume 1, Issue 2, Pages (July 2014)
Living in colour—American children, race, and wellbeing
Refining treatment choices for ADHD
Clinic attendance and disengagement of young adults with type 1 diabetes after transition of care from paediatric to adult services (TrACeD): a randomised,
Pleurodesis for primary spontaneous pneumothorax – Authors' reply
Economic decline, incarceration, and mortality from drug use disorders in the USA between 1983 and 2014: an observational analysis  Elias Nosrati, PhD,
Autism, maths, and sex: the special triangle
C1 esterase inhibitor concentrates and attenuated androgens
Reversible biological adaptations in obesity
Presentation transcript:

Sacubitril/valsartan in PARADIGM-HF Nicolas Vodovar, Hélène Nougué, Jean-Marie Launay, Alain Cohen Solal, Damien Logeart  The Lancet Diabetes & Endocrinology  Volume 5, Issue 7, Pages 495-496 (July 2017) DOI: 10.1016/S2213-8587(17)30177-8 Copyright © 2017 Elsevier Ltd Terms and Conditions

Figure Concentration of GLP-1 (7–36) amide in plasma from 27 patients before and after sacubitril/valsartan treatment Circles indicate individual patient data, the central bar is the median, the outer box is the IQR, and whiskers indicate the 1·5 IQR. GLP-1 (7–36) amide=active amidated form of glucagon-like peptide-1. The Lancet Diabetes & Endocrinology 2017 5, 495-496DOI: (10.1016/S2213-8587(17)30177-8) Copyright © 2017 Elsevier Ltd Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.